Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

Usefulness of new diagnostic criteria for chronic hypersensitivity pneumonitis established on the basis of a Delphi survey: A Japanese cohort study.

Takei R, Yamano Y, Kataoka K, Yokoyama T, Matsuda T, Kimura T, Johkoh T, Tabata K, Fukuoka J, Kondoh Y.

Respir Investig. 2019 Nov 9. pii: S2212-5345(19)30115-7. doi: 10.1016/j.resinv.2019.10.001. [Epub ahead of print]

PMID:
31718936
2.

A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea CPAP Management.

Murase K, Tanizawa K, Minami T, Matsumoto T, Tachikawa R, Takahashi N, Tsuda T, Toyama Y, Ohi M, Akahoshi T, Tomita Y, Narui K, Nakamura H, Ohdaira T, Yoshimine H, Tsuboi T, Yamashiro Y, Ando S, Kasai T, Kita H, Tatsumi K, Burioka N, Tomii K, Kondoh Y, Takeyama H, Handa T, Hamada S, Oga T, Nakayama T, Sakamaki T, Morita S, Kuroda T, Hirai T, Chin K.

Ann Am Thorac Soc. 2019 Nov 5. doi: 10.1513/AnnalsATS.201907-494OC. [Epub ahead of print]

PMID:
31689141
3.

Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF).

Saito S, Alkhatib A, Kolls JK, Kondoh Y, Lasky JA.

J Thorac Dis. 2019 Sep;11(Suppl 14):S1740-S1754. doi: 10.21037/jtd.2019.04.62. Review.

4.

Abscisic Acid Derivatives with Different Alkyl Chain Lengths Activate Distinct Abscisic Acid Receptor Subfamilies.

Yoshida K, Kondoh Y, Iwahashi F, Nakano T, Honda K, Nagano E, Osada H.

ACS Chem Biol. 2019 Sep 20;14(9):1964-1971. doi: 10.1021/acschembio.9b00453. Epub 2019 Sep 9.

PMID:
31497942
5.

Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.

Fukihara J, Sakamoto K, Koyama J, Ito T, Iwano S, Morise M, Ogawa M, Kondoh Y, Kimura T, Hashimoto N, Hasegawa Y.

Clin Lung Cancer. 2019 Nov;20(6):442-450.e4. doi: 10.1016/j.cllc.2019.07.006. Epub 2019 Aug 1.

PMID:
31446020
6.

Acute exacerbations of fibrotic interstitial lung diseases.

Suzuki A, Kondoh Y, Brown KK, Johkoh T, Kataoka K, Fukuoka J, Kimura T, Matsuda T, Yokoyama T, Fukihara J, Ando M, Tanaka T, Hashimoto N, Sakamoto K, Hasegawa Y.

Respirology. 2019 Aug 19. doi: 10.1111/resp.13682. [Epub ahead of print]

PMID:
31426125
7.

Mechanism of Action of Prethioviridamide, an Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptide with a Polythioamide Structure.

Takase S, Kurokawa R, Kondoh Y, Honda K, Suzuki T, Kawahara T, Ikeda H, Dohmae N, Osada H, Shin-Ya K, Kushiro T, Yoshida M, Matsumoto K.

ACS Chem Biol. 2019 Aug 16;14(8):1819-1828. doi: 10.1021/acschembio.9b00410. Epub 2019 Jul 31.

PMID:
31365229
8.

Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.

Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, Poletti V, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown KK, Corte TJ, Cottin V, Crestani B, Flaherty KR, Glaspole IN, Grutters J, Inoue Y, Kondoh Y, Kreuter M, Johannson KA, Ley B, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts WA, Wells AU.

Am J Respir Crit Care Med. 2019 Nov 1;200(9):1146-1153. doi: 10.1164/rccm.201903-0493OC.

9.

Diagnostic difficulty in idiopathic pulmonary fibrosis.

Kondoh Y.

Respir Investig. 2019 Jul;57(4):298-299. doi: 10.1016/j.resinv.2019.03.012. Epub 2019 May 14. No abstract available.

PMID:
31097397
10.

Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study.

Enomoto N, Egashira R, Tabata K, Hashisako M, Kitani M, Waseda Y, Ishizuka T, Watanabe S, Kasahara K, Izumi S, Shiraki A, Miyamoto A, Kishi K, Kishaba T, Sugimoto C, Inoue Y, Kataoka K, Kondoh Y, Tsuchiya Y, Baba T, Sugiura H, Tanaka T, Sumikawa H, Suda T.

Sci Rep. 2019 May 14;9(1):7355. doi: 10.1038/s41598-019-43782-7.

11.

Pulmonary interstitial emphysema is a risk factor for poor prognosis and a cause of air leaks.

Tachibana Y, Taniguchi H, Kondoh Y, Kataoka K, Hamada N, Hashiguchi T, Ichikado K, Kishaba T, Sato S, Udo E, Hashisako M, Fukuoka J.

Respir Investig. 2019 Sep;57(5):444-450. doi: 10.1016/j.resinv.2019.03.008. Epub 2019 Apr 28.

PMID:
31043328
12.

Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.

Watanabe K, Ishii H, Kiyomi F, Terasaki Y, Hebisawa A, Kawabata Y, Johkoh T, Sakai F, Kondoh Y, Inoue Y, Azuma A, Suda T, Ogura T, Inase N, Homma S; Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases in Japan.

Respir Investig. 2019 Jul;57(4):312-320. doi: 10.1016/j.resinv.2019.02.007. Epub 2019 Apr 10. Review.

PMID:
30981683
13.

Performance of the COPD Assessment Test in patients with connective tissue disease-associated interstitial lung disease.

Suzuki A, Kondoh Y, Swigris JJ, Matsuda T, Kimura T, Kataoka K, Ando M, Hashimoto N, Sakamoto K, Hasegawa Y.

Respir Med. 2019 Apr;150:15-20. doi: 10.1016/j.rmed.2019.01.017. Epub 2019 Feb 1.

PMID:
30961943
14.

Development of Mirror-Image Screening Systems for XIAP BIR3 Domain Inhibitors.

Shu K, Iwamoto N, Honda K, Kondoh Y, Hirano H, Osada H, Ohno H, Fujii N, Oishi S.

Bioconjug Chem. 2019 May 15;30(5):1395-1404. doi: 10.1021/acs.bioconjchem.9b00154. Epub 2019 Apr 17.

PMID:
30888797
15.

Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.

Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Hashisako M, Tanaka T, Terasaki Y, Kunugi S, Kitani M, Okuda R, Horiike Y, Enomoto Y, Yasui H, Hozumi H, Suzuki Y, Nakamura Y, Fukuoka J, Johkoh T, Kondoh Y, Ogura T, Inoue Y, Hasegawa Y, Inase N, Homma S, Suda T.

Eur Respir J. 2019 May 18;53(5). pii: 1802243. doi: 10.1183/13993003.02243-2018. Print 2019 May.

16.

Synthesis and structure-activity relationships of pyrazine-2-carboxamide derivatives as novel echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) inhibitors.

Iikubo K, Kurosawa K, Matsuya T, Kondoh Y, Kamikawa A, Moritomo A, Iwai Y, Tomiyama H, Shimada I.

Bioorg Med Chem. 2019 Apr 15;27(8):1683-1692. doi: 10.1016/j.bmc.2019.03.018. Epub 2019 Mar 7.

PMID:
30878193
17.

Screening and identification of a non-peptide antagonist for the peptide hormone receptor in Arabidopsis.

Shinohara H, Yasue N, Onuki T, Kondoh Y, Yoshida M, Matsubayashi Y.

Commun Biol. 2019 Feb 15;2:61. doi: 10.1038/s42003-019-0307-8. eCollection 2019.

18.

Identification of a chemical modulator of EZH2-mediated silencing by cell-based high-throughput screening assay.

Murashima A, Shinjo K, Katsushima K, Onuki T, Kondoh Y, Osada H, Kagaya N, Shin-Ya K, Kimura H, Yoshida M, Murakami S, Kondo Y.

J Biochem. 2019 Jul 1;166(1):41-50. doi: 10.1093/jb/mvz007.

PMID:
30690451
19.

Miscorrelation of Functional Outcome and Sociooccupational Status of Childhood, Adolescent, and Young Adult Generation With Bone and Soft Tissue Sarcoma Patients.

Fujii H, Honoki K, Ishihara T, Shinomiya T, Tsukamoto S, Kido A, Kondoh Y, Kishi S, Shima M, Tanaka Y.

J Pediatr Hematol Oncol. 2019 Mar;41(2):112-117. doi: 10.1097/MPH.0000000000001410.

PMID:
30688829
20.

A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration.

Suvarna K, Honda K, Muroi M, Kondoh Y, Osada H, Watanabe N.

J Biol Chem. 2019 Mar 1;294(9):2988-2996. doi: 10.1074/jbc.RA118.004741. Epub 2019 Jan 4.

PMID:
30610116
21.

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.

Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180074. doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31. Review.

22.

Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias.

Ozasa M, Ichikawa H, Sato S, Tanaka T, Johkoh T, Kataoka K, Yamano Y, Kondoh Y, Nakamura H, Kawakami A, Bychkov A, Taniguchi H, Fukuoka J.

PLoS One. 2018 Nov 5;13(11):e0206186. doi: 10.1371/journal.pone.0206186. eCollection 2018.

23.

Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.

Teramachi R, Kondoh Y, Kataoka K, Taniguchi H, Matsuda T, Kimura T, Yokoyama T, Yamano Y, Furukawa T, Sakamoto K, Hashimoto N, Hasegawa Y.

Respir Med. 2018 Oct;143:147-152. doi: 10.1016/j.rmed.2018.09.011. Epub 2018 Sep 13.

PMID:
30261987
24.

Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective.

Saito S, Lasky JA, Hagiwara K, Kondoh Y.

Respir Investig. 2018 Sep;56(5):375-383. doi: 10.1016/j.resinv.2018.06.002. Epub 2018 Jul 27. Review.

PMID:
30061050
25.

Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan.

Ishii H, Watanabe K, Kushima H, Baba T, Watanabe S, Yamada Y, Arai T, Tsushima K, Kondoh Y, Nakamura Y, Terasaki Y, Hebisawa A, Johkoh T, Sakai F, Takemura T, Kawabata Y, Ogura T; Tokyo Diffuse Lung Disease Study Group.

Respir Med. 2018 Aug;141:190-197. doi: 10.1016/j.rmed.2018.06.022. Epub 2018 Jun 27.

PMID:
30053966
26.

Multidimensional improvement in connective tissue disease-associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus.

Yamano Y, Taniguchi H, Kondoh Y, Ando M, Kataoka K, Furukawa T, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

Respirology. 2018 Nov;23(11):1041-1048. doi: 10.1111/resp.13365. Epub 2018 Jul 16.

27.

Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema.

Suzuki A, Kimura T, Kataoka K, Matsuda T, Yokoyama T, Mori Y, Kondoh Y.

Respir Med Case Rep. 2018 Jan 31;23:103-106. doi: 10.1016/j.rmcr.2018.01.004. eCollection 2018.

28.

Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy.

Kondoh Y, Taniguchi H, Kataoka K, Furukawa T, Shintani A, Fujisawa T, Suda T, Arita M, Baba T, Ichikado K, Inoue Y, Kishi K, Kishaba T, Nishiyama O, Ogura T, Tomii K, Homma S.

PLoS One. 2018 Mar 28;13(3):e0193608. doi: 10.1371/journal.pone.0193608. eCollection 2018.

29.

Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease.

Suzuki A, Kondoh Y, Swigris JJ, Ando M, Kimura T, Kataoka K, Yamano Y, Furukawa T, Numata M, Sakamoto K, Hasegawa Y.

Respirology. 2018 Mar 25. doi: 10.1111/resp.13293. [Epub ahead of print]

PMID:
29575410
30.

Respiratory failure patient with lung cancer diagnosed by transesophageal bronchoscopic ultrasound-guided aspirates.

Ito T, Oki M, Saka H, Kondoh Y, Kimura T, Kataoka K.

Respirol Case Rep. 2018 Feb 28;6(4):e00309. doi: 10.1002/rcr2.309. eCollection 2018 May.

31.
32.

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.

Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R, Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H, Watashi K.

Sci Rep. 2018 Feb 9;8(1):2769. doi: 10.1038/s41598-018-20987-w.

33.

Identification of a small-molecule ligand of ╬▓-arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells.

Suvarna K, Honda K, Kondoh Y, Osada H, Watanabe N.

Cancer Med. 2018 Mar;7(3):883-893. doi: 10.1002/cam4.1339. Epub 2018 Jan 29.

34.

A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis.

Furukawa T, Kondoh Y, Taniguchi H, Yagi M, Matsuda T, Kimura T, Kataoka K, Johkoh T, Ando M, Hashimoto N, Sakamoto K, Hasegawa Y.

Eur Respir J. 2018 Jan 18;51(1). pii: 1701311. doi: 10.1183/13993003.01311-2017. Print 2018 Jan.

35.

A Volumetric Computed Tomography Analysis of the Normal Lung in Idiopathic Pulmonary Fibrosis: The Relationship with the Survival.

Ohkubo H, Taniguchi H, Kondoh Y, Yagi M, Furukawa T, Johkoh T, Arakawa H, Fukuoka J, Niimi A.

Intern Med. 2018 Apr 1;57(7):929-937. doi: 10.2169/internalmedicine.9508-17. Epub 2017 Dec 21.

36.

Palliative care in interstitial lung disease: living well.

Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Johannson KA, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris J, Udwadia Z, Wells A, Wijsenbeek M.

Lancet Respir Med. 2017 Dec;5(12):968-980. doi: 10.1016/S2213-2600(17)30383-1. Epub 2017 Oct 13. Review.

37.

Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.

Kondoh Y, Cottin V, Brown KK.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170050. doi: 10.1183/16000617.0050-2017. Print 2017 Sep 30. Review. Erratum in: Eur Respir Rev. 2018 Apr 13;27(148):.

38.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

39.

Disease severity staging system for idiopathic pulmonary fibrosis in Japan.

Kondoh Y, Taniguchi H, Kataoka K, Furukawa T, Ando M, Murotani K, Mishima M, Inoue Y, Ogura T, Bando M, Hagiwara K, Suda T, Chiba H, Takahashi H, Sugiyama Y, Homma S.

Respirology. 2017 Nov;22(8):1609-1614. doi: 10.1111/resp.13138. Epub 2017 Aug 8.

PMID:
28787101
40.

Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.

Otsubo K, Kishimoto J, Kenmotsu H, Minegishi Y, Ichihara E, Shiraki A, Kato T, Atagi S, Horinouchi H, Ando M, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakanishi Y, Okamoto I.

Clin Lung Cancer. 2018 Jan;19(1):e5-e9. doi: 10.1016/j.cllc.2017.06.003. Epub 2017 Jun 20.

PMID:
28687482
41.

Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.

Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Nishimura K, Nishiyama O, Sakamoto K, Hasegawa Y.

Intern Med. 2017;56(13):1637-1644. doi: 10.2169/internalmedicine.56.7019. Epub 2017 Jul 1.

42.

Recent advances in connective tissue disease related interstitial lung disease.

Suzuki A, Kondoh Y, Fischer A.

Expert Rev Respir Med. 2017 Jul;11(7):591-603. doi: 10.1080/17476348.2017.1335600. Epub 2017 Jun 2.

PMID:
28544856
43.

CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.

Yagi M, Taniguchi H, Kondoh Y, Ando M, Kimura T, Kataoka K, Furukawa T, Suzuki A, Johkoh T, Hasegawa Y.

Respirology. 2017 Oct;22(7):1393-1399. doi: 10.1111/resp.13066. Epub 2017 May 10.

PMID:
28488784
44.

Identification of a trichothecene production inhibitor by chemical array and library screening using trichodiene synthase as a target protein.

Maeda K, Nakajima Y, Motoyama T, Kondoh Y, Kawamura T, Kanamaru K, Ohsato S, Nishiuchi T, Yoshida M, Osada H, Kobayashi T, Kimura M.

Pestic Biochem Physiol. 2017 May;138:1-7. doi: 10.1016/j.pestbp.2017.03.006. Epub 2017 Mar 22.

PMID:
28456298
45.

Investigation of the inhibitory mechanism of apomorphine against MDM2-p53 interaction.

Ishiba H, Noguchi T, Shu K, Ohno H, Honda K, Kondoh Y, Osada H, Fujii N, Oishi S.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2571-2574. doi: 10.1016/j.bmcl.2017.03.082. Epub 2017 Mar 29.

PMID:
28400230
46.

Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.

Chutiwitoonchai N, Mano T, Kakisaka M, Sato H, Kondoh Y, Osada H, Kotani O, Yokoyama M, Sato H, Aida Y.

Virology. 2017 Jul;507:32-39. doi: 10.1016/j.virol.2017.04.001. Epub 2017 Apr 8.

47.

The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.

Suzuki A, Kondoh Y.

Respir Investig. 2017 Mar;55(2):94-103. doi: 10.1016/j.resinv.2016.11.004. Epub 2017 Jan 14. Review.

PMID:
28274539
48.

Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.

Fukihara J, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Furukawa T, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

BMC Pulm Med. 2017 Feb 6;17(1):30. doi: 10.1186/s12890-017-0376-8.

49.

Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction.

Teramachi R, Taniguchi H, Kondoh Y, Ando M, Kimura T, Kataoka K, Suzuki A, Furukawa T, Sakamoto K, Hasegawa Y.

Respirology. 2017 Jul;22(5):986-990. doi: 10.1111/resp.12986. Epub 2017 Jan 24.

PMID:
28117530
50.

The St. George's Respiratory Questionnaire as a prognostic factor in IPF.

Furukawa T, Taniguchi H, Ando M, Kondoh Y, Kataoka K, Nishiyama O, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

Respir Res. 2017 Jan 17;18(1):18. doi: 10.1186/s12931-017-0503-3.

Supplemental Content

Loading ...
Support Center